Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Alinamin
2. Prosultiamine Hydrochloride
3. Thiamine Propyl Disulfide
4. Thiamine Propyldisulfide
5. Thiamine Propyldisulphide
6. Thiaminepropyldisulfide
1. 59-58-5
2. Thiamine Propyl Disulfide
3. N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-n-[(z)-5-hydroxy-3-(propyldisulfanyl)pent-2-en-2-yl]formamide
4. Jubedel
5. Taketron
6. Thiobeta
7. Binova
8. Thiamine Propyldisulfide
9. Thiamine Propyl Disulphide
10. Prosultiamin
11. Ncgc00167447-01
12. Alinamin (tn)
13. Prosultiamine (jan/inn)
14. Chembl1442890
15. Schembl19533173
16. Zinc1608677
17. Mfcd00023265
18. Akos037643219
19. As-11046
20. D03286
21. 023p265
22. [[(2-methyl-4-aminopyrimidine-5-yl)methyl][(z)-1-methyl-2-(propyldithio)-4-hydroxy-1-butenyl]amino]formaldehyde
23. N-[(4-amino-2-methyl-5-pyrimidyl)-methyl]-n-[4-hydroxy-1-methyl-2-(propyldithio)-1-butenyl]formamide
| Molecular Weight | 356.5 g/mol |
|---|---|
| Molecular Formula | C15H24N4O2S2 |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 9 |
| Exact Mass | 356.13406837 g/mol |
| Monoisotopic Mass | 356.13406837 g/mol |
| Topological Polar Surface Area | 143 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 396 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Market Place
ABOUT THIS PAGE
A Prosultiamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Prosultiamine, including repackagers and relabelers. The FDA regulates Prosultiamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Prosultiamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Prosultiamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Prosultiamine supplier is an individual or a company that provides Prosultiamine active pharmaceutical ingredient (API) or Prosultiamine finished formulations upon request. The Prosultiamine suppliers may include Prosultiamine API manufacturers, exporters, distributors and traders.
click here to find a list of Prosultiamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Prosultiamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Prosultiamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Prosultiamine GMP manufacturer or Prosultiamine GMP API supplier for your needs.
A Prosultiamine CoA (Certificate of Analysis) is a formal document that attests to Prosultiamine's compliance with Prosultiamine specifications and serves as a tool for batch-level quality control.
Prosultiamine CoA mostly includes findings from lab analyses of a specific batch. For each Prosultiamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Prosultiamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Prosultiamine EP), Prosultiamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Prosultiamine USP).
LOOKING FOR A SUPPLIER?
